Finland · Delayed Price · Currency is EUR Bittium Oyj Earnings Call Transcripts
Fiscal Year 2026
-
Net sales surged 60% in Q2 and 37.2% in H1, driven by Defence & Security, which saw record order intake and profitability. Medical turned profitable, while Engineering Services declined. Strong cash flow, a net debt free position, and robust outlook support continued growth.
Fiscal Year 2025
-
Strong 2025 growth driven by defense segment, record order intake, and international expansion. 2026 guidance projects further sales and profit increases, with major licensing deals and new product development supporting long-term growth.
-
The updated strategy targets accelerated international growth, with a focus on defense, medical, and engineering services. Financial targets have been raised to 20%-30% annual net sales growth and 10%-20% operating profit margin, supported by new partnerships, AI integration, and a shift to a more customer-driven, scalable business model.
-
Net sales grew 11.3% year-on-year in the first half, driven by strong defense and security segment growth and a robust order book. Profitability was impacted by growth investments and a one-time medical segment restructuring, but the outlook remains positive with full-year guidance reaffirmed.
Fiscal Year 2024
-
Net sales grew 13.2% year-on-year to EUR 85.2 million, with strong gains in Defense & Security and improved cash flow. 2025 guidance projects further growth, supported by a robust order book and ongoing strategic initiatives.
-
Net sales rose 6.5% year-over-year in H1 2024, with improved operating results and a strong order book. Defense and Security saw robust growth, while Medical and Engineering Services faced regulatory and market challenges. Full-year guidance remains positive.